We are live on ! Find out more
ANVS icon

Annovis Bio

13 hedge funds and large institutions have $5.73M invested in Annovis Bio in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

277% more capital invested

Capital invested by funds: $1.52M → $5.73M (+$4.21M)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

8% more funds holding

Funds holding: 1213 (+1)

6.44% more ownership

Funds ownership: 4.59%11.03% (+6.4%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ANVS Hedge Fund Activity: Q4 2020 in Review

13 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q4 2020, worth a combined $5.73M — up 277% from $1.52M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ANVS positions and 3 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Modera Wealth Management, opening a new position worth an estimated $237K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $99K sold.

  • 13 institutional investors held Annovis Bio (ANVS) as of Q4 2020, up from 12 in Q3 2020.
  • Funds reported $5.73M of Annovis Bio stock for Q4 2020, up 277% quarter-over-quarter.
  • 5 funds opened new Annovis Bio positions in Q4 2020 and 3 closed out, a net change of +2 holders.
  • The largest Annovis Bio buyer in Q4 2020 was Modera Wealth Management, an estimated $237K added.
  • The largest Annovis Bio seller in Q4 2020 was Renaissance Technologies, an estimated $99K sold.

Based on aggregated 13F filings for Q4 2020.